✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Valiant Laboratories Ltd.

VALIANTLAB

Market Cap
₹468 Cr.
P/E
0.00

Valiant Laboratories Ltd.

  • Valiant Laboratories
  • Albert David
  • Chandan Healthcare
FAQs on Valiant Laboratories Ltd. Shareprice

Valiant Laboratories has given lower returns compared to its competitors.
Valiant Laboratories has grown at ~-25.17% over the last 1yrs while peers have grown at a median rate of 13.0%

Valiant Laboratories is not expensive.
Latest PE of Valiant Laboratories is 0.0, while 3 year average PE is 9.61.
Also latest EV/EBITDA of Valiant Laboratories is 0.0 while 3yr average is 11.71.

View FAQ's On Business
Growth Table
  • Valiant Laboratories Ltd.
  • Albert David
  • Chandan Healthcare
Balance Sheet
  • Valiant Laboratories Ltd.
  • Albert David
  • Chandan Healthcare
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Valiant Laboratories Ltd.
  • Albert David
  • Chandan Healthcare
Cash Flow
  • Valiant Laboratories Ltd.
  • Albert David
  • Chandan Healthcare
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Valiant Laboratories Ltd.
  • Albert David
  • Chandan Healthcare
Quarterly Results
  • Valiant Laboratories Ltd.
  • Albert David
  • Chandan Healthcare
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Valiant Laboratories Ltd. Financials

Balance sheet of Valiant Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Valiant Laboratories is increasing.
Latest net debt of Valiant Laboratories is ₹45.21 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹124.71 Crs.

No, profit is decreasing.
The profit of Valiant Laboratories is -₹2.2 Crs for TTM, ₹0.32 Crs for Mar 2024 and ₹29 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Valiant Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech